We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DGI
1376
DELISTED
DigitalGlobe Inc.
DGI
| $2.71M | 0.01% |
82,827
+2,891
| +4% | +$88.3K |
|
|
TGI
1377
DELISTED
Triumph Group
TGI
| $2.71M | 0.01% |
105,075
+4,922
| +5% | +$129K |
|
1378
Tenet Healthcare
THC
$20.5B
| $2.7M | 0.01% |
152,633
+3,998
| +3% | +$74.2K |
|
|
TYPE
1379
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $2.7M | 0.01% |
134,454
+25,786
| +24% | +$539K |
|
|
FLOW
1380
DELISTED
SPX FLOW, Inc.
FLOW
| $2.7M | 0.01% |
77,812
+18,539
| +31% | +$633K |
|
1381
Tennant Co
TNC
$1.43B
| $2.69M | 0.01% |
37,096
+9,563
| +35% | +$674K |
|
|
ECHO
1382
EchoStar
ECHO
$24.4B
| $2.69M | 0.01% |
58,373
+4,112
| +8% | +$179K |
|
|
HRG
1383
DELISTED
HRG Group, Inc.
HRG
| $2.68M | 0.01% |
138,641
+5,600
| +4% | +$98.3K |
|
|
SAGE
1384
DELISTED
Sage Therapeutics
SAGE
| $2.67M | 0.01% |
37,587
+1,458
| +4% | +$85.4K |
|
1385
Ormat Technologies
ORA
$6B
| $2.67M | 0.01% |
46,722
+2,118
| +5% | +$117K |
|
|
NVRO
1386
DELISTED
NEVRO CORP.
NVRO
| $2.65M | 0.01% |
28,339
+1,100
| +4% | +$99.6K |
|
1387
8x8 Inc
EGHT
$269M
| $2.64M | 0.01% |
173,384
+50,730
| +41% | +$769K |
|
1388
AAR Corp
AIR
$5.59B
| $2.63M | 0.01% |
78,323
+20,021
| +34% | +$665K |
|
1389
Seaboard Corp
SEB
$4.23B
| $2.62M | 0.01% |
629
+12
| +2% | +$46.9K |
|
1390
Comfort Systems
FIX
$60.9B
| $2.62M | 0.01% |
71,477
+20,825
| +41% | +$723K |
|
|
ZEN
1391
DELISTED
ZENDESK INC
ZEN
| $2.62M | 0.01% |
93,393
+4,412
| +5% | +$114K |
|
1392
STAG Industrial
STAG
$7.38B
| $2.61M | 0.01% |
104,402
+17,197
| +20% | +$420K |
|
1393
Wabash National
WNC
$512M
| $2.61M | 0.01% |
126,088
+29,774
| +31% | +$583K |
|
1394
The Greenbrier Companies
GBX
$1.52B
| $2.6M | 0.01% |
60,411
+16,029
| +36% | +$708K |
|
|
NE
1395
DELISTED
Noble Corporation
NE
| $2.6M | 0.01% |
420,654
+14,480
| +4% | +$97.5K |
|
|
ABCO
1396
DELISTED
Advisory Board Co
ABCO
| $2.6M | 0.01% |
55,602
+1,541
| +3% | +$68K |
|
|
CKH
1397
DELISTED
Seacor Holdings Inc.
CKH
| $2.6M | 0.01% |
38,852
+9,453
| +32% | +$646K |
|
|
MDC
1398
DELISTED
M.D.C. Holdings, Inc.
MDC
| $2.6M | 0.01% |
108,902
+31,457
| +41% | +$709K |
|
1399
First Commonwealth Financial
FCF
$2.18B
| $2.59M | 0.01% |
195,561
+48,753
| +33% | +$673K |
|
|
NTUS
1400
DELISTED
Natus Medical Inc
NTUS
| $2.59M | 0.01% |
65,987
+17,670
| +37% | +$663K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.